EMERGENT BIOSOLUTIONS INC. Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax
EMERGENT BIOSOLUTIONS INC. (EBS) had Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax of $9.00 million as of 2022-12-31, per its 10-K filed 2024-03-08.
Discontinued › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax
us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax · last filed 2024-03-08
- 2022-12-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax $9.00M.
- 2021-12-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax $5.90M; Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax as first filed -$5.90M.
- 2020-12-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax -$9.90M.
- 2019-12-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax -$5.40M.
| Period end | Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax | Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax as first filed |
|---|---|---|
| 2022-12-31 | $9.00M 10-K · filed 2024-03-08 | |
| 2021-12-31 | $5.90M 10-K/A · filed 2023-12-11 | -$5.90M 10-K · filed 2022-02-25 |
| 2020-12-31 | -$9.90M 10-K · filed 2022-02-25 | |
| 2019-12-31 | -$5.40M 10-K · filed 2021-02-19 | |
| 2018-12-31 | -$100.00K 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |